13 March 2020
Visiongain has launched a new pharma report: Global Live Vaccines Market Forecast 2020-2030: Bacterial, Viral, Oral Polio Vaccine, Measles, Rotavirus, Tuberculosis, Yellow Fever, Oral, Injectable, End Users, Hospitals, Specialty Clinics, Others.
Live attenuated vaccines contain weakened versions of the live virus to create a protective immune response in healthy individuals. They include vaccines for measles, mumps and rubella (MMR), varicella (chickenpox), Oral Polio Vaccine (OPV) etc. The resurgence of interest in vaccine research has been underpinned by the rapidly expanding body of knowledge in the fields of microbial pathogenesis and immunology. This has advanced the ability of researchers and manufacturers to create both preventive and therapeutic vaccines and target new diseases.
The lead analyst of the report commented "There are a number of innovative vaccines in the pipeline, which will enter the market in the coming decade. Advancements in technology will lead to improvements in the efficacy & coverage of vaccines. The recent rise in global disease outbreaks such as Ebola, Zika, Nipah and 1N1 virus has further increased demand for vaccines and galvanised vaccine advocacy. The Asia Pacific region will be the fastest growing submarket, due to a rise in governments implementing national immunisation policies & public awareness initiatives by organisations like WHO."
Leading companies featured in the report include AstraZeneca, Bavarian Nordic A/S, DAIICHI SANKYO COMPANY, LIMITED, Emergent BioSolutions Inc., GlaxoSmithKline plc, Inovio Pharmaceuticals, Inc. & Other Companies.
Notes for Editors
If you are interested in a more detailed overview of this report, please send an e-mail to firstname.lastname@example.org or call her on +44 (0) 207 336 6100.
Visiongain is one of the fastest-growing and most innovative independent media companies in Europe. Based in London, UK, Visiongain produces a host of business-to-business reports focusing on the automotive, aviation, chemicals, cyber, defence, energy, food & drink, materials, packaging, pharmaceutical and utilities sectors.
Visiongain publishes reports produced by analysts who are qualified experts in their field. Visiongain has firmly established itself as the first port of call for the business professional who needs independent, high-quality, original material to rely and depend on.
The increasing rates of patent expiry lead to a counter-strategy of switching companies from Rx to OTC. In the US, according to the Consumer Healthcare Products Association, approximately 106 ingredients and dosage strengths have undergone a change from Rx to OTC to around 700 OTC products on the market.
23 September 2020
. The growth of this market is majorly driven by increasing sales of temperature sensitive pharmaceutical products, longer life expectancy and rising geriatric population are some of the prominent factors.
16 September 2020
Visiongain forecasts a continuing growth in global market, submarket and product sales as human vaccines drive pharmaceutical business sales. New key players and technological progress will enter the industry, leading to an increase in the market size of the world market for human vaccines in general.
14 September 2020
The global ophthalmic ultrasound systems market is driven by factors such as the increasing prevalence of ocular disorders and diseases, adoption of novel ophthalmic technologies, rising focus on research & development, and growing health awareness amongst the population.